Clinical review report: Dolutegravir (Tivicay)
The objective of this review is to evaluate the beneficial and harmful effects of Dolutegravir (DTG) at recommended doses in combination with other antiretroviral drugs for the treatment of HIV infection in antiretroviral drugs(ART)-naive and ART-experienced patients
| Corporate Author: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa (ON)
Canadian Agency for Drugs and Technologies in Health
August 2014, 2014
|
| Series: | CADTH common drug review
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | The objective of this review is to evaluate the beneficial and harmful effects of Dolutegravir (DTG) at recommended doses in combination with other antiretroviral drugs for the treatment of HIV infection in antiretroviral drugs(ART)-naive and ART-experienced patients |
|---|---|
| Physical Description: | 1 PDF file (xii, 84 pages) illustrations |